Colin J, Tournoux A, Chastel C, Renard G
Nouv Presse Med. 1981 Oct 10;10(36):2969-70, 2975.
In a double-blind, randomized trial 52 patients with superficial herpes simplex keratitis were treated with a new antiviral compound, acylclovir (ACV) 3% ointment, or with idoxuridine (IDU) 0.5% ointment. No statistically significant difference was found in the number of patients cured with either drug, but healing was achieved more rapidly with ACV than with IDU.
在一项双盲随机试验中，52例单纯疱疹性浅层角膜炎患者分别接受一种新型抗病毒化合物阿昔洛韦（ACV）3%眼膏或碘苷（IDU）0.5%眼膏治疗。两种药物治愈的患者数量未发现有统计学显著差异，但阿昔洛韦的愈合速度比碘苷更快。
Zotero 插件